However,The patients with largest nodule diameter of > 8 cm and serum AFP of > 1000 ng/mL will be categorized in the high-risk category (Table 3), so LT should be excluded or neoadjuvant therapy and close surveillance until the tumor biology and morphology could be brought down to a safer level. This evidence concerns the gene AFP and neoplasm.